UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Has $53.43 Million Stock Holdings in Eastman Chemical Company $EMN

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Eastman Chemical Company (NYSE:EMN) by 4.2% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 606,354 shares of the basic materials company’s stock after purchasing an additional 24,183 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned approximately 0.53% of Eastman Chemical worth $53,426,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in EMN. Brighton Jones LLC acquired a new stake in shares of Eastman Chemical during the fourth quarter worth approximately $202,000. Focus Partners Wealth increased its holdings in shares of Eastman Chemical by 65.6% during the fourth quarter. Focus Partners Wealth now owns 4,988 shares of the basic materials company’s stock worth $492,000 after buying an additional 1,976 shares in the last quarter. Janus Henderson Group PLC increased its holdings in shares of Eastman Chemical by 98.0% during the fourth quarter. Janus Henderson Group PLC now owns 25,480 shares of the basic materials company’s stock worth $2,326,000 after buying an additional 12,612 shares in the last quarter. Millennium Management LLC increased its holdings in shares of Eastman Chemical by 6,019.3% during the fourth quarter. Millennium Management LLC now owns 114,676 shares of the basic materials company’s stock worth $10,472,000 after buying an additional 112,802 shares in the last quarter. Finally, Nuveen Asset Management LLC increased its holdings in shares of Eastman Chemical by 2.4% during the fourth quarter. Nuveen Asset Management LLC now owns 249,867 shares of the basic materials company’s stock worth $22,818,000 after buying an additional 5,933 shares in the last quarter. Institutional investors and hedge funds own 83.65% of the company’s stock.

Wall Street Analyst Weigh In

EMN has been the subject of several recent analyst reports. The Goldman Sachs Group dropped their price objective on shares of Eastman Chemical from $87.00 to $65.00 and set a “neutral” rating for the company in a report on Thursday, August 7th. Mizuho dropped their price objective on shares of Eastman Chemical from $92.00 to $80.00 and set an “outperform” rating for the company in a report on Friday, August 1st. UBS Group dropped their price objective on shares of Eastman Chemical from $107.00 to $101.00 and set a “buy” rating for the company in a report on Wednesday, July 9th. KeyCorp set a $79.00 price objective on shares of Eastman Chemical and gave the stock an “overweight” rating in a report on Monday, August 4th. Finally, Royal Bank Of Canada decreased their price target on shares of Eastman Chemical from $91.00 to $74.00 and set an “outperform” rating on the stock in a research note on Tuesday, August 5th. Eight investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $87.00.

Eastman Chemical Price Performance

Shares of EMN stock opened at $67.07 on Monday. Eastman Chemical Company has a 52-week low of $56.78 and a 52-week high of $114.50. The stock has a market cap of $7.70 billion, a PE ratio of 9.42, a PEG ratio of 6.47 and a beta of 1.26. The company has a debt-to-equity ratio of 0.81, a quick ratio of 0.78 and a current ratio of 1.68. The firm’s 50 day moving average price is $70.58 and its two-hundred day moving average price is $77.87.

Eastman Chemical (NYSE:EMN) last announced its quarterly earnings data on Thursday, July 31st. The basic materials company reported $1.60 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.72 by ($0.12). Eastman Chemical had a net margin of 8.96% and a return on equity of 15.24%. The business had revenue of $2.29 billion during the quarter, compared to the consensus estimate of $2.32 billion. During the same period in the previous year, the business posted $2.15 earnings per share. Eastman Chemical’s revenue was down 3.2% compared to the same quarter last year. Eastman Chemical has set its Q3 2025 guidance at 1.250-1.250 EPS. As a group, analysts forecast that Eastman Chemical Company will post 8.55 EPS for the current year.

Eastman Chemical Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 7th. Shareholders of record on Monday, September 15th will be paid a $0.83 dividend. The ex-dividend date of this dividend is Monday, September 15th. This represents a $3.32 dividend on an annualized basis and a yield of 5.0%. Eastman Chemical’s dividend payout ratio (DPR) is presently 46.63%.

Eastman Chemical Company Profile

Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.